Dr. Chad Broome-Webster, MD
What this data tells you about Dr. Broome-Webster
Dr. Chad Broome-Webster is a nuclear cardiology physician in Orange City, FL, with 19 years in practice. Based on federal Medicare data, Dr. Broome-Webster performed 4,374 Medicare services across 2,936 unique beneficiaries.
Between the years covered by Open Payments, Dr. Broome-Webster received a total of $2,850 from 24 pharmaceutical and/or device companies across 148 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear cardiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Broome-Webster is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 838 | $6 | $28 |
| Office visit, established patient (30-39 min) | 816 | $92 | $185 |
| Electrocardiogram (EKG), 12-lead | 623 | $11 | $42 |
| Initial hospital admission, high complexity | 284 | $137 | $300 |
| Regadenoson injection (Lexiscan) for heart stress test | 196 | $43 | $100 |
| Echocardiogram, transthoracic | 147 | $143 | $400 |
| Remote pacemaker/defibrillator monitoring, 90 days | 127 | $17 | $70 |
| Remote pacemaker monitoring, 90 days | 124 | $23 | $75 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 124 | $88 | $175 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 109 | $26 | $70 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 98 | $19 | $56 |
| Hospital follow-up visit, high complexity | 95 | $93 | $150 |
| Programming of dual lead pacemaker system | 77 | $59 | $125 |
| Office visit, established patient, complex (40-54 min) | 70 | $138 | $250 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 67 | $48 | $200 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 63 | $50 | $200 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 62 | $330 | $800 |
| Evaluation of implantable heart and blood vessel monitoring system | 61 | $35 | $60 |
| Infusion, normal saline solution, 250 cc | 61 | $1 | $25 |
| Programming of multiple lead implantable defibrillator system | 43 | $82 | $200 |
| New patient office visit (45-59 min) | 40 | $105 | $285 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $10 | $100 |
| Office visit, established patient (20-29 min) | 36 | $56 | $120 |
| Programming of single lead pacemaker system | 30 | $52 | $115 |
| Ultrasound of both sides of head and neck blood flow | 20 | $146 | $365 |
| Ultrasound of within the brain blood flow | 20 | $99 | $190 |
| Ultrasound of heart, follow-up | 17 | $19 | $99 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $14 | $52 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $2 | $15 |
| Hospital follow-up visit, moderate complexity | 16 | $63 | $100 |
| Drug infusion during cardiac catheterization | 14 | $77 | $200 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $6 | $22 |
| Cardiac catheterization | 12 | $236 | $700 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Broome-Webster is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Broome-Webster experienced with ekg interpretation and report?
Does Dr. Broome-Webster receive payments from pharmaceutical companies?
How do Dr. Broome-Webster's costs compare to other nuclear cardiology physicians in Orange City?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology